The store will not work correctly when cookies are disabled.
all-cis-2,3,4,4a,9,9a-Hexahydro-9-phenyl-1H-indeno-[2,1-c]pyridine Hydrobromide
ID: ALA3249179
PubChem CID: 12412644
Max Phase: Preclinical
Molecular Formula: C18H20BrN
Molecular Weight: 249.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Br.c1ccc([C@@H]2c3ccccc3[C@@H]3CCNC[C@H]23)cc1
Standard InChI: InChI=1S/C18H19N.BrH/c1-2-6-13(7-3-1)18-16-9-5-4-8-14(16)15-10-11-19-12-17(15)18;/h1-9,15,17-19H,10-12H2;1H/t15-,17-,18+;/m0./s1
Standard InChI Key: WNEMIFFVIDUJMK-TZQBAMPOSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
14.9398 -18.3853 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
12.9844 -17.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2710 -17.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2732 -16.4252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9888 -16.0146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7022 -16.4290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7000 -17.2540 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4857 -17.5030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0026 -16.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1823 -16.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8488 -15.9913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3355 -15.3251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1558 -15.4136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4893 -16.1681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2286 -18.2869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4212 -18.4563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1642 -19.2402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7146 -19.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5220 -19.6854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7791 -18.9015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2668 -15.6000 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
12.2668 -18.0751 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
2 7 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
3 8 1 0
4 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
8 15 1 6
4 21 1 1
3 22 1 1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.36 | Molecular Weight (Monoisotopic): 249.1517 | AlogP: 3.53 | #Rotatable Bonds: 1 |
Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.23 | CX LogP: 3.47 | CX LogD: 0.78 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.82 | Np Likeness Score: 0.35 |
References
1. Ellefson CR, Woo CM, Cusic JW.. (1978) Synthesis and antiarrhythmic activity of 2-dialkylaminoalkyl-9-phenyl-1H-indeno[2,1-c]pyridine derivatives., 21 (4): [PMID:650662] [10.1021/jm00202a005] |